SCHEMBL10098672

SCHEMBL10098672

CCN(CC)c1ccc2c(=O)c3ccccc3c(=O)oc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 13/20 0.59
▸ KDM4E B2RXH2 9/20 0.59
▸ HTT P42858 5/20 0.59
▸ TDP1 Q9NUW8 4/20 0.59
▸ MEN1 O00255 8/20 0.58
▸ KMT2A Q03164 8/20 0.58
▸ ATM Q13315 7/20 0.58
▸ GLA P06280 7/20 0.58
▸ MAPT P10636 7/20 0.58
▸ L3MBTL1 Q9Y468 6/20 0.58
▸ CASP1 P29466 5/20 0.58
▸ CASP7 P55210 5/20 0.58
▸ HSD17B10 Q99714 5/20 0.58
▸ NPSR1 Q6W5P4 4/20 0.58
▸ CYP3A4 P08684 3/20 0.58
▸ CYP1A2 P05177 3/20 0.58
▸ CYP2C19 P33261 3/20 0.58
▸ TP53 P04637 2/20 0.58
▸ CYP2C9 P11712 2/20 0.58
▸ LMNA P02545 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30025646 1.00 ALDH1A1 (0.59) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL29582092 0.86 ALDH1A1 (0.67) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL7230127 0.86 ALDH1A1 (0.67) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL13869376 0.80 ALDH1A1 (0.68) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL11296750 0.79 ALDH1A1 (0.78) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL5590828 0.76 ALDH1A1 (0.78) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL18655467 0.76 ALDH1A1 (0.67) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL7730304 0.75 ALDH1A1 (0.68) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL12651890 0.75 ALDH1A1 (0.72) ALDH1A1KDM4EHTTTDP1MEN1
SCHEMBL21456977 0.75 ALDH1A1 (0.67) ALDH1A1KDM4EHTTTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2142165-B1 CRYSTAL MODIFICATIONS OF TRANSMISSION DYES BASF SE (DE) 2016-08-17 — — EP disclosed
EP-1986749-B1 USE OF TRANSMISSION DYES FOR PROTECTING HUMAN SKIN FROM BROWNING AND AGEING BASF SE (DE) 2014-06-18 — — EP disclosed
US-8557820-B2 Crystal modifications of transmission dyes BASF SE (DE) 2013-10-15 — — US disclosed
US-8557820-B2 Crystal modifications of transmission dyes BASF SE (DE) 2013-10-15 — — US disclosed
US-8097240-B2 Use of transmission dyes for protecting human skin from browning and ageing BASF SE (DE) 2012-01-17 — — US disclosed
US-8097240-B2 Use of transmission dyes for protecting human skin from browning and ageing BASF SE (DE) 2012-01-17 — — US disclosed
US-7999128-B2 Hydroxybenzophenone derivatives BASF SE (DE) 2011-08-16 — — US disclosed
US-7999128-B2 Hydroxybenzophenone derivatives BASF SE (DE) 2011-08-16 — — US disclosed
US-20100144753-A1 CRYSTAL MODIFICATIONS OF TRANSMISSION DYES CIBA CORPORATION (US) 2010-06-10 — — US disclosed
US-20100144753-A1 CRYSTAL MODIFICATIONS OF TRANSMISSION DYES CIBA CORPORATION (US) 2010-06-10 — — US disclosed
US-20090220439-A1 Hydroxybenzophenone Derivatives BASF SE (DE) 2009-09-03 — — US disclosed
US-20090220439-A1 Hydroxybenzophenone Derivatives BASF SE (DE) 2009-09-03 — — US disclosed
US-20090214453-A1 Use of Transmission Dyes for Protecting Human Skin From Browning and Ageing BASF SE (DE) 2009-08-27 — — US disclosed
US-20090214453-A1 Use of Transmission Dyes for Protecting Human Skin From Browning and Ageing BASF SE (DE) 2009-08-27 — — US disclosed
WO-2008135421-A2 CRYSTAL MODIFICATIONS OF TRANSMISSION DYES BASF SE (CH) 2008-11-13 — — WO disclosed
US-7374749-B2 Amino substituted hydroxyphenyl benzophenone derivatives CIBA SPECIALTY CHEMICALS CORP. (US) 2008-05-20 — — US disclosed
US-7374749-B2 Amino substituted hydroxyphenyl benzophenone derivatives CIBA SPECIALTY CHEMICALS CORP. (US) 2008-05-20 — — US disclosed
WO-2007090832-A1 HYDROXYBENZOPHENONE DERIVATIVES CIBA HOLDING INC. (CH) 2007-08-16 — — WO disclosed
WO-2007071584-A2 USE OF TRANSMISSION DYES FOR PROTECTING HUMAN SKIN FROM BROWNING AND AGEING CIBA HOLDING INC. (CH) 2007-06-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090214453-A1 Use of Transmission Dyes for Protecting Human Skin From Browning and Ageing CUTA, TYR, GLA ALDH1A1 269/4885KDM4E 4122/4885HTT 522/4885
US-20090220439-A1 Hydroxybenzophenone Derivatives CYP1B1, CYP8B1, C1S ALDH1A1 74/4885KDM4E 2529/4885HTT 1728/4885
US-20100144753-A1 CRYSTAL MODIFICATIONS OF TRANSMISSION DYES MITF, CUTA, RCC1 ALDH1A1 242/4885KDM4E 1814/4885HTT 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback